Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chandra Prakash Vijay Kumar Serkad"'
Autor:
Xi Zhang, Aparna Gunda, Elma Meershoek-Klein Kranenbarg, Gerrit-Jan Liefers, Badada Ananthamurthy Savitha, Payal Shrivastava, Chandra Prakash Vijay Kumar Serkad, Taranjot Kaur, Mallikarjuna Siraganahalli Eshwaraiah, Rob A. E. M. Tollenaar, Cornelis J. H. van de Velde, Caroline M. J. Seynaeve, Manjiri Bakre, Peter J. K. Kuppen
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background Hormone receptor (HR)-positive, HER2/neu-negative breast cancers have a sustained risk of recurrence up to 20 years from diagnosis. TEAM (Tamoxifen, Exemestane Adjuvant Multinational) is a large, multi-country, phase III trial tha
Externí odkaz:
https://doaj.org/article/3d99b753ff134f63ac6057c295814442
Autor:
Zhang, Xi, Gunda, Aparna, Kranenbarg, Elma Meershoek-Klein, Liefers, Gerrit-Jan, Savitha, Badada Ananthamurthy, Shrivastava, Payal, Serkad, Chandra Prakash Vijay Kumar, Kaur, Taranjot, Eshwaraiah, Mallikarjuna Siraganahalli, Tollenaar, Rob A. E. M., van de Velde, Cornelis J. H., Seynaeve, Caroline M. J., Bakre, Manjiri, Kuppen, Peter J. K.
Publikováno v:
Breast Cancer Research; 4/14/2023, Vol. 25 Issue 1, p1-11, 11p
Publikováno v:
Women's Health Weekly; 5/2/2023, p849-849, 1p